e-learning
resources
Virtual 2021
05.09.2021
Lung graft allocation and monitoring in the 21st century
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The lung in a box: ex vivo monitoring of donor lungs and clinical implications for lung preservation, repair and utilisation
C. Divithotawela (Gaythorne (QLD), Australia)
Source:
Virtual Congress 2021 – Lung graft allocation and monitoring in the 21st century
Session:
Lung graft allocation and monitoring in the 21st century
Session type:
Symposium
Number:
1347
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Divithotawela (Gaythorne (QLD), Australia). The lung in a box: ex vivo monitoring of donor lungs and clinical implications for lung preservation, repair and utilisation. Virtual Congress 2021 – Lung graft allocation and monitoring in the 21st century
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Improving donor organ quality: the role of ex vivo lung perfusion
Source: International Congress 2019 – ME2 Improving donor organ quality: the role of ex vivo lung perfusion
Year: 2019
Potential therapeutic targets for lung repair during human
ex vivo
lung perfusion
Source: Eur Respir J, 55 (4) 1902222; 10.1183/13993003.02222-2019
Year: 2020
Ex vivo lung repair: rebuilding a new lung
Source: Annual Congress 2013 –What's new in thoracic surgery: highlights for the pulmonologist
Year: 2013
Neutrophil extracellular traps in
ex vivo
lung perfusion perfusate predict the clinical outcome of lung transplant recipients
Source: Eur Respir J, 53 (4) 1801736; 10.1183/13993003.01736-2018
Year: 2019
An
in vivo
comparison of two lung function systems
Source: Eur Respir J 2005; 26: Suppl. 49, 177s
Year: 2005
Ex vivo donor lung perfusion
Source: School Course 2012 - Lung Transplantation
Year: 2012
The use of a murine model of brain death for mechanistic studies on treatment for donor lung injury
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011
Unravelling specific mechanisms of wound healing and pulmonary fibrosis in human ex vivo lung tissue slices
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Year: 2018
Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis
ex vivo
Source: Eur Respir J, 50 (2) 1602367; 10.1183/13993003.02367-2016
Year: 2017
CT imaging-based study of ventilation heterogeneity in smokers :the respective roles of unequal lung expansion and peripheral lung structure.
Source: International Congress 2019 – Imaging for prognostication and disease characterisation: 2019 update
Year: 2019
LSC - 2017 - Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo
Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis
Year: 2017
Precision cut lung slices from bleomycin challenged mice – ex vivo model for testing novel therapies for lung fibrosis
Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease
Year: 2019
Towards human lung regeneration in end-stage respiratory failure: genetically-modifiable 3D organoid culture of human embryonic lung stem cells enables for the first time the study of human lung development in vitro
Source: ERS Lung Science Conference 2018
Year: 2018
Progress towards human lung regeneration in end-stage respiratory failure: studying human lung development in vitro using organoid cultures of human embryonic lung stem cells
Source: International Congress 2018 – Cell-matrix interactions in lung disease and regeneration
Year: 2018
Pro-fibrotic biomarkers in ex vivo lung tissue slices: A species comparison
Source: International Congress 2017 – Lung fibrosis: basic science
Year: 2017
Systematic differences in lung function outcomes in a new lung function lab.
Source: International Congress 2017 – Discussion of techniques and technologies in lung function
Year: 2017
Monitoring of lung function and bronchial inflammation after bone marrow transplantation: preferential recruitment of lymphocytes into the airways
Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs
Year: 2006
Strategies to increase limited donor resources
Source: Eur Respir J 2004; 23: 477-482
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept